HbO2 Therapeutics Company Profile, Contacts & Intelligence

Biotechnology ResearchSouderton, Pennsylvania, United States8 employeesFounded 2014
2 contacts with email or phone data2 with email data1 with phone data
View verified contacts Compare competitors
Employees
8
Company source estimate
Reachable Contacts
2
Visible contacts with email or phone data
Contacts With Email
2
2 of 4 visible contacts
Departments
2
Mapped contact coverage

HbO2 Therapeutics Overview

Hemoglobin Oxygen Therapeutics LLC (HbO2 Therapeutics) is a leading developer and manufacturer of oxygen carrying solutions, a class of drug products that when administered intravenously can increase the amount of oxygen transported throughout the body. We have developed two products. Hemopure® [hemoglobin glutamer – 250 (bovine)], for use in humans, and Oxyglobin® [hemoglobin glutamer – 200 (bovine)]) for veterinary use. Oxyglobin is the only oxygen carrying solution approved by the FDA and the European Medicines Agency (EMA) to treat all cause canine anemia. Hemopure is approved in South Africa to treat adult surgical patients who are anemic, and in the Russian Federation for acute anemia, irrespective of etiology. In the US Hemopure is only available under investigational status through the FDA expanded access program to qualifying patients with severe, life threatening anemia for whom blood transfusion is not an option, and who have exhausted all other treatment options. Blood transfusion may not be an option due to religious beliefs, or because no compatible blood is available for a patient needing transfusion.

Headquarters
Souderton, Pennsylvania, United States
Website
hbo2therapeutics.com
Industry
Biotechnology Research
Founded
2014
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads

HbO2 Therapeutics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

2 contacts with contact data
2 with email data and 1 with phone data in the visible sample.
2 departments represented
Visible contacts with email or phone data are mapped to these departments.
2 company-domain emails
Visible contacts using HbO2 Therapeutics's company email domain.
General
1
Executive
1

HbO2 Therapeutics People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

F
Fantao Meng
Director of Research Development at Hbo2 Therapeutics
E
G
Gregory P. Dubé, Ph.d.
Vice President, Research and Development
EP
N
Nicole Arena-Burton
Finance Manager at Hemoglobin Oxygen Therapeutics Llc
B
Bucksar Richard
Process Development Engineer at Hbo2 Therapeutics

HbO2 Therapeutics Workforce Composition

Seniority breakdown across 5 visible profiles.

Executive
1
Director
1
Manager
1
Individual contributor
1
Intern / trainee
1

Compare Similar Companies to HbO2 Therapeutics

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
MYBALI COFFEE Consumer Goods 12 View company
Conifer Point Pharmaceuticals Biotechnology Research 11 View company
ECM Therapeutics, Inc. Biotechnology Research 9 View company
NexEos Bio Pharmaceutical Manufacturing 9 View company
FloBio LLC Medical Device 4 View company
Innate Biologics, LLC Biotechnology 3 View company
Prolifagen Biotechnology 3 View company
Fathom Pharma Biotechnology Research 2 View company
Neurokappa Therapeutics Llc Multi-signal peer 1 View company
Hemoglobin Oxygen Therapeutics LLC Pharmaceutical Manufacturing Not listed View company